reports
Key Figures 15.11.2024
HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 15.11.2024 18.11.2024 / 17:47 CET/CEST in CHF Performance in % 15.11.2024 MTD FYTD CYTD NAV 251.81 0.5 4.5 15.2 Share Price 189.00 0.7 1.5 7.6 Total Net Assets (in million) 1'711 HBM Healthcare Investments AG Bundesplatz 1 CH-6300 Zug - Swit...
HBM Healthcare Investments AG: 1 director
A director at HBM Healthcare Investments AG bought 500 shares at 182.248CHF and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two...
Key Figures 31.10.2024
HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 31.10.2024 04.11.2024 / 17:47 CET/CEST in CHF Performance in % 31.10.2024 MTD FYTD CYTD NAV 250.49 2.5 4.0 14.6 Share Price 187.60 -1.0 0.8 6.8 Total Net Assets (in million) 1'704 HBM Healthcare Investments AG Bundesplatz 1 CH-6300 Zug - Swi...
Key Figures 15.10.2024
HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 15.10.2024 16.10.2024 / 17:47 CET/CEST in CHF Performance in % 15.10.2024 MTD FYTD CYTD NAV 249.16 2.0 3.4 14.1 Share Price 184.60 -2.5 -0.8 5.2 Total Net Assets (in million) 1'697 HBM Healthcare Investments AG Bundesplatz 1 CH-6300 Zug - Sw...
Erfolgreicher Börsengang des HBM-Portfoliounternehmens Upstream Bio; K...
HBM Healthcare Investments AG / Schlagwort(e): Börsengang Erfolgreicher Börsengang des HBM-Portfoliounternehmens Upstream Bio; Kapitalaufnahme von USD 255 Millionen 14.10.2024 / 06:30 CET/CEST Upstream Bio (Nasdaq: UPB), ein bisher privates Unternehmen aus dem Portfolio von HBM Healthcare Investments, legte am vergangenen Freitag einen erfolgreichen Start an der Börse hin. Das Unternehmen nahm durch die Ausgabe von 15 Millionen Aktien zu einem Preis von USD 17.00 pro Aktie USD 255 Millionen an neuem Kapital auf. Der Aktienkurs stieg am ersten Handelstag auf USD 22.00 (+29....
HBM portfolio company Upstream Bio raises USD 255 million in successfu...
HBM Healthcare Investments AG / Key word(s): IPO HBM portfolio company Upstream Bio raises USD 255 million in successful initial public offering 14.10.2024 / 06:30 CET/CEST Upstream Bio (Nasdaq: UPB), a previously private company in the HBM Healthcare Investments portfolio, got off to a successful start on the stock market last Friday. The company raised USD 255 million in new capital through the issuance of 15 million shares at a price of USD 17.00 per share. The share price rose to USD 22.00 (+29.4%) on the first day of trading, valuing the company at around USD 1.1 bill...
Key Figures 30.9.2024
HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 30.9.2024 01.10.2024 / 17:47 CET/CEST in CHF Performance in % 30.09.2024 MTD FYTD CYTD NAV 244.34 5.6 1.5 11.9 Share Price 189.40 4.6 1.7 7.8 Total Net Assets (in million) 1'664 HBM Healthcare Investments AG Bundesplatz 1 CH-6300 Zug - Switz...
Key Figures 15.9.2024
HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 15.9.2024 16.09.2024 / 17:47 CET/CEST in CHF Performance in % 15.09.2024 MTD FYTD CYTD NAV* 229.03 -1.0 -4.7 5.1 Share Price 164.00 -9.4 -11.4 -6.1 Total Net Assets (in million) 1'562 HBM Healthcare Investments AG Bundesplatz 1 CH-6300 Zug -...
Key Figures 31.8.2024
HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 31.8.2024 02.09.2024 / 17:46 CET/CEST in CHF Performance in % 31.08.2024 MTD FYTD CYTD NAV* 231.29 -1.8 -3.8 6.1 Share Price* 181.00 -4.3 -2.6 3.2 Total Net Assets (in million) 1'578 HBM Healthcare Investments AG Bundesplatz 1 CH-6300 Zug - ...
Key Figures 15.8.2024
HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 15.8.2024 16.08.2024 / 17:47 CET/CEST in CHF Performance in % 15.08.2024 MTD FYTD CYTD NAV* 232.50 -1.3 -3.3 6.7 Share Price* 184.00 -2.8 -1.1 4.9 Total Net Assets (in million) 1'587 HBM Healthcare Investments AG Bundesplatz 1 CH-6300 Zug - ...
Key Figures 31.7.2024
HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 31.7.2024 02.08.2024 / 17:46 CET/CEST in CHF Performance in % 31.07.2024 MTD FYTD CYTD NAV 243.25 -3.5 -2.0 8.1 Share Price 197.00 -3.9 1.8 7.9 Total Net Assets (in million) 1'661 HBM Healthcare Investments AG Bundesplatz 1 CH-6300 Zug - Swi...
Key Figures 15.7.2024
HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 15.7.2024 16.07.2024 / 17:46 CET/CEST in CHF Performance in % 15.07.2024 MTD FYTD CYTD NAV 251.97 0.0 1.6 12.0 Share Price 200.00 -2.4 3.3 9.5 Total Net Assets (in million) 1'721 HBM Healthcare Investments AG Bundesplatz 1 CH-6300 Zug - Swit...
Key Figures 30.06.2024
HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 30.06.2024 01.07.2024 / 17:46 CET/CEST in CHF Performance in % 30.06.2024 MTD FYTD CYTD NAV 252.07 -1.8 1.6 12.0 Share Price 205.00 -1.4 5.9 12.3 Total Net Assets (in million) 1'722 HBM Healthcare Investments AG Bundesplatz 1 CH-6300 Zug - S...
Shareholders’ Meeting of HBM Healthcare Investments approved all propo...
HBM Healthcare Investments AG / Key word(s): AGMEGM Shareholders’ Meeting of HBM Healthcare Investments approved all proposals by the Board of Directors 17.06.2024 / 17:53 CET/CEST At today’s ordinary Shareholders’ Meeting of HBM Healthcare Investments Ltd the shareholders approved all proposals submitted by the Board of Directors. The Chairman of the Board of Directors Hans Peter Hasler and the existing board members Dr Rudolf Lanz, Mario G. Giuliani, Dr Stella X. Xu and Dr Elaine V. Jones were re-elected for a further one y...
Generalversammlung der HBM Healthcare Investments stimmt allen Anträge...
HBM Healthcare Investments AG / Schlagwort(e): Generalversammlung Generalversammlung der HBM Healthcare Investments stimmt allen Anträgen des Verwaltungsrats zu 17.06.2024 / 17:53 CET/CEST Die Aktionärinnen und Aktionäre haben an der heutigen ordentlichen Generalversammlung der HBM Healthcare Investments AG allen Anträgen des Verwaltungsrats zugestimmt. Der Verwaltungsratspräsident Hans Peter Hasler und die bestehenden Verwaltungsratsmitglieder Dr. Rudolf Lanz, Mario G. Giuliani, Dr. Stella X. Xu und Dr. Elaine V. Jones wurden für eine weitere Amtsdauer von einem Jahr wi...
Key Figures 15.06.2024
HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 15.06.2024 17.06.2024 / 17:46 CET/CEST in CHF Performance in % 15.06.2024 MTD FYTD CYTD NAV 251.13 -2.2 1.2 11.6 Share Price 206.50 -0.7 6.7 13.1 Total Net Assets (in million) 1'717 HBM Healthcare Investments AG Bundesplatz 1 CH-6300 Zug - S...
Key Figures 31.05.2024
HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 31.05.2024 03.06.2024 / 17:46 CET/CEST in CHF Performance in % 31.05.2024 MTD FYTD CYTD NAV 256.74 0.8 3.5 14.1 Share Price 208.00 11.6 7.4 13.9 Total Net Assets (in million) 1'757 HBM Healthcare Investments AG Bundesplatz 1 CH-6300 Zug - Sw...
HBM Healthcare Investments' portfolio company Swixx BioPharma boosts s...
HBM Healthcare Investments AG / Key word(s): Acquisition HBM Healthcare Investments' portfolio company Swixx BioPharma boosts sales and profits through strategic acquisition in Latin America 22.05.2024 / 18:17 CET/CEST Swixx BioPharma, the largest investment in the private equity portfolio of HBM Healthcare Investments, today announced its strategic expansion into Latin America with the signing of an agreement to acquire the Laboratorios Biopas Group. The acquisition of Biopas builds on Swixx BioPharma’s rapid rate of organic growth and extends & transforms the company’s...
HBM Healthcare Investments’ Portfoliounternehmen Swixx BioPharma stärk...
HBM Healthcare Investments AG / Schlagwort(e): Ankauf HBM Healthcare Investments’ Portfoliounternehmen Swixx BioPharma stärkt Umsatz und Gewinn durch strategische Übernahme in Lateinamerika 22.05.2024 / 18:17 CET/CEST Swixx BioPharma, die grösste Beteiligung im Private-Equity-Portfolio der HBM Healthcare Investments, gab heute mit der Unterzeichnung einer Vereinbarung zur Übernahme der Laboratorios Biopas Gruppe seine strategische Expansion nach Lateinamerika bekannt. Die Übernahme von Biopas baut auf dem schnellen organischen Wachstum von Swixx BioPharma auf und erweite...
HBM Healthcare Investments’ Portfoliounternehmen Swixx BioPharma stärk...
HBM Healthcare Investments AG / Schlagwort(e): Ankauf HBM Healthcare Investments’ Portfoliounternehmen Swixx BioPharma stärkt Umsatz und Gewinn durch strategische Übernahme in Lateinamerika 22.05.2024 / 17:46 CET/CEST Swixx BioPharma, die grösste Beteiligung im Private-Equity-Portfolio der HBM Healthcare Investments, gab heute mit der Unterzeichnung einer Vereinbarung zur Übernahme der Laboratorios Biopas Gruppe seine strategische Expansion nach Lateinamerika bekannt. Die Übernahme von Biopas baut auf dem schnellen organischen Wachstum von Swixx BioPharma auf und erweite...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.